Search
for
Sort by
Research 121–150 of 790
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Baricitinib: A Review in Severe Alopecia Areata
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Spotlight in Plastic Surgery: October 2022
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)